Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Delphi Ventures, established in 1988, is a venture capital firm headquartered in San Mateo, California. The firm has a long history of focusing on early-stage investments in the healthcare sector, particularly in medical devices, biotechnology, and diagnostics. Over its three decades of operation, Delphi Ventures has built a reputation for its collaborative approach and extensive network within the healthcare industry.
With a commitment to fostering innovation, Delphi Ventures has successfully exited multiple public companies, including Tandem Diabetes Care and PTC Therapeutics. The firm has a diverse portfolio that reflects its focus on therapeutics, diagnostics, and medical devices, with a particular interest in oncology, cardiology, neurology, diabetes, and rare diseases.
Delphi Ventures continues to operate with a strong emphasis on partnering with companies that possess solid scientific foundations and significant market potential. The firm’s long-standing presence in the Bay Area positions it as a key player in the healthcare venture capital space.
Delphi Ventures specializes in early-stage investments within the healthcare sector, targeting companies in therapeutics, diagnostics, and medical devices. The firm is particularly interested in sub-sectors such as oncology, cardiology, neurology, diabetes, and rare diseases. Delphi Ventures seeks to partner with companies that demonstrate strong scientific foundations and significant market potential.
The firm typically invests in Seed, Series A, and Series B stages, allowing it to engage with startups at critical points in their development. Delphi Ventures emphasizes a collaborative approach, leveraging its extensive network to facilitate partnerships and provide strategic guidance to portfolio companies. This approach enhances growth and innovation within the healthcare space.
Delphi Ventures looks for founders who are deeply knowledgeable about their fields and possess a clear vision for their companies. The firm values strong scientific research and a well-defined market strategy, which are essential for successful investments in the competitive healthcare landscape.
Delphi Ventures has a notable portfolio that includes several successful companies in the healthcare sector. Key portfolio companies include:
This diverse portfolio showcases Delphi Ventures' commitment to advancing healthcare innovation through strategic investments in companies with strong growth potential.
Doug Roeder: Managing Partner since 2000, Doug joined Delphi Ventures as an Associate in 1998. He focuses on medical devices, diagnostics, and biotechnology. Doug serves on the board of Senseonics Holdings, contributing his expertise in healthcare investments.
To pitch Delphi Ventures, founders should prepare a detailed deck that includes information about their business model, market strategy, and scientific research. A warm introduction is preferred, but cold outreach is also accepted. Response times may vary, but founders can expect to hear back within a few weeks after submission.
As of 2023, Delphi Ventures remains active in the venture capital space, although specific recent deal activity has not been publicly reported. The firm continues to support its portfolio companies, including Senseonics, where Doug Roeder serves as a board director. Notable past exits include Tandem Diabetes Care and PTC Therapeutics, showcasing the firm's successful track record in the healthcare sector.
What are Delphi Ventures' investment criteria?
Delphi Ventures focuses on early-stage healthcare investments, particularly in therapeutics, diagnostics, and medical devices. The firm looks for companies with strong scientific foundations and significant market potential, especially in oncology, cardiology, neurology, diabetes, and rare diseases.
How can I pitch to Delphi Ventures?
Founders interested in pitching to Delphi Ventures should prepare a clear and concise presentation that outlines their business model, market strategy, and scientific basis. A warm introduction is preferred, but cold outreach is also accepted.
What makes Delphi Ventures different from other VCs?
Delphi Ventures distinguishes itself through its long-standing focus on healthcare and its collaborative approach with portfolio companies. The firm leverages its extensive network to facilitate partnerships and provide strategic guidance, enhancing the growth of its investments.
What is the geographic focus of Delphi Ventures?
Delphi Ventures primarily invests in companies based in North America, allowing it to maintain close relationships with its portfolio companies and the healthcare ecosystem.
What is the typical check size for investments?
While specific check sizes are not publicly disclosed, Delphi Ventures typically invests in Seed, Series A, and Series B rounds, which generally range from hundreds of thousands to several million dollars.
What kind of post-investment involvement does Delphi Ventures have?
Delphi Ventures takes an active role in supporting its portfolio companies through strategic guidance, access to resources, and leveraging its network to facilitate partnerships that drive growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.